Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of IM Ziprasidone for Psychotic Agitation
NCT02935998Phase 4Unknown
- Start
- Oct 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ziprasidone in psychomotor agitation. Status: unknown.
02
Drugs
ziprasidone
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT02935998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935998.